Extendicare Market Cap

Extendicare has a market cap or net worth of $819.45 million as of August 14, 2025. Its market cap has increased by 77.11% in one year.

Market Cap

819.45M

Enterprise Value

973.07M

Revenue

1.11B

Ranking

n/a

PE Ratio

13.44

Stock Price

$9.81

Market Cap Chart

Since May 15, 1997, Extendicare's market cap has decreased from 973.52M to 819.45M, a decrease of -15.83%. That is a compound annual growth rate of -0.61%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	819.45M	32.89%
Dec 31, 2024	616.65M	33.95%
Dec 29, 2023	460.35M	11.06%
Dec 30, 2022	414.49M	-19.77%
Dec 31, 2021	516.64M	10.73%
Dec 31, 2020	466.60M	-19.54%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Nika Pharmaceuticals	972.93M
Veradigm	806.69M
Tian'an Technology Group	628.15M
Elite Pharmaceuticals	625.65M
Glass House Brands	497.52M
Northwest Biotherapeutics	367.14M
American Oncology Network	353.52M
CytoDyn	322.85M

Market Cap Rankings